StockData
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30

Immuron Ltd

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026
$0.96−0.03 (-2.62%)

Close on Oct 19, 2026

Immuron Ltd revenue by segment

No segment breakdown reported

Immuron does not break out revenue by segment, region or product in the tagged data of its filings for this period type.